Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Aeolus Pharmaceuticals, Inc.
(OP:
AOLS
)
0.3998
USD
+0.0098 (+2.51%)
Official Closing Price
/ Updated:
5:20 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
32,700
Open
0.4065
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.3900
Today's Range
0.3750 - 0.4100
52wk Range
0.2800 - 0.4750
Shares Outstanding
134,550,068
Dividend Yield
N/A
Top News
More News
Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans
May 17, 2013
from
Marketwired News Releases
Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2013 Financial Results
May 15, 2013
from
Marketwired News Releases
More News
Read More
10th Annual Taglich Brothers Small Cap Equity Conference Agenda
May 01, 2013
from
PRWeb
Aeolus Pharmaceuticals To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
April 18, 2013
from
PRWeb
Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013
March 14, 2013
from
Marketwired News Releases
Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2013 Financial Results
February 19, 2013
from
Marketwired News Releases
Aeolus Pharmaceuticals Announces $3.2 Million Private Placement Financing
February 19, 2013
from
Marketwired News Releases
Aeolus Pharmaceuticals Provides Positive Update on FDA Meeting
September 06, 2012
from
Marketwired News Releases
Roth Capital Downgrades Aeolus Pharmaceuticals (AOLS) to Neutral
August 20, 2012
from
StreetInsider.com News Articles
Aeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2012 Financial Results
August 14, 2012
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here